专利检索 ap:"Targazyme, Inc." 第 1 页

1.

发明公开
Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase 审中-公开

公开(公告)号：US20230416681A9

公开(公告)日：2023-12-28

申请号：US16135487

申请日：2018-09-19

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , C12N5/00 , C12N5/0775 , C12N5/0789 , A61K35/17 , C12N5/0797 , A61K35/12

CPC分类号： C12N5/0638 , C12Y204/01065 , C12N5/0637 , C12N5/0006 , C12N5/0663 , C12N5/0647 , A61K35/17 , C12N5/0623 , A61K2035/124 , C12N2501/724

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

2.

发明申请
Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase 审中-公开

公开(公告)号：US20190017023A1

公开(公告)日：2019-01-17

申请号：US16135487

申请日：2018-09-19

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , C12N5/00 , C12N5/0775 , C12N5/0789 , A61K35/17 , C12N5/0797 , A61K35/12

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

3.

发明授权
Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase 有权

公开(公告)号：US11976298B2

公开(公告)日：2024-05-07

申请号：US16135487

申请日：2018-09-19

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , A61K35/17 , C12N5/00 , C12N5/0775 , C12N5/0789 , C12N5/0797 , A61K35/12

CPC分类号： C12N5/0638 , A61K35/17 , C12N5/0006 , C12N5/0623 , C12N5/0637 , C12N5/0647 , C12N5/0663 , C12Y204/01065 , A61K35/12 , A61K2035/124 , C12N2501/70 , C12N2501/724

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

4.

发明申请
Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use 审中-公开

公开(公告)号：US20190062694A1

公开(公告)日：2019-02-28

申请号：US16150681

申请日：2018-10-03

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe

IPC分类号： C12N5/00 , A61K39/00 , A01N1/02 , A61K35/12 , A61K35/17 , C12N9/10 , A61K35/44 , A61K35/28

摘要： Compositions for and methods of manufacturing a fucosylated cell population are provided. The method may include expansion of the cells and/or cryopreservation of the cells under conditions that retain optimum levels of cell surface fucosylation.

5.

发明公开
AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE 审中-公开

公开(公告)号：US20240271093A1

公开(公告)日：2024-08-15

申请号：US18629323

申请日：2024-04-08

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , A61K35/12 , A61K35/17 , C12N5/00 , C12N5/0775 , C12N5/0789 , C12N5/0797

CPC分类号： C12N5/0638 , A61K35/17 , C12N5/0006 , C12N5/0623 , C12N5/0637 , C12N5/0647 , C12N5/0663 , C12Y204/01065 , A61K35/12 , A61K2035/124 , C12N2501/70 , C12N2501/724

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

6.

发明申请
MANUFACTURE AND CRYOPRESERVATION OF FUCOSYLATED CELLS FOR THERAPEUTIC USE 有权

公开(公告)号：US20230014609A1

公开(公告)日：2023-01-19

申请号：US17816616

申请日：2022-08-01

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe

IPC分类号： C12N5/00 , A61K35/17 , A61K35/28 , A61K35/12 , C12N9/10 , A01N1/02 , A61K35/44

摘要： Compositions for and methods of manufacturing a fucosylated cell population are provided. The method may include expansion of the cells and/or cryopreservation of the cells under conditions that retain optimum levels of cell surface fucosylation.

7.

发明申请
Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use 审中-公开

公开(公告)号：US20170121673A1

公开(公告)日：2017-05-04

申请号：US15322565

申请日：2015-07-07

申请人： Targazyme, Inc.

发明人： Stephen D. WOLPE

IPC分类号： C12N5/00 , A61K39/00 , A61K35/28 , A61K35/44 , A01N1/02 , C12N9/10

CPC分类号： C12N5/0006 , A01N1/0221 , A01N1/0284 , A61K35/12 , A61K35/17 , A61K35/28 , A61K35/44 , A61K39/0011 , A61K2039/5158 , A61K2039/572 , A61K2039/585 , C12N9/1051 , C12N2501/724 , C12Y204/01065

摘要： Compositions for and methods of manufacturing a fucosylated cell population are provided. The method may include expansion of the cells and/or cryopreservation of the cells under conditions that retain optimum levels of cell surface fucosylation.

8.

发明申请
Augmentation of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase 审中-公开
标题翻译：细胞治疗功效的增强包括用Alpha 1,3岩藻糖基转移酶治疗

公开(公告)号：US20170058261A1

公开(公告)日：2017-03-02

申请号：US15347500

申请日：2016-11-09

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh

IPC分类号： C12N5/0783 , A61K35/17 , C12N5/00

CPC分类号： C12N5/0638 , A61K35/17 , A61K2035/124 , C12N5/0006 , C12N5/0623 , C12N5/0637 , C12N5/0647 , C12N5/0663 , C12N2501/724 , C12Y204/01065

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

摘要翻译： 公开了用于通过离体处理后细胞膜性质的改变来增加细胞的方法，物质组合物和试剂盒。

9.

发明申请
AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSLYTRANSFERASE 审中-公开
标题翻译：细胞治疗效果的补充，包括用ALPHA治疗1-3 FUCOSLYTRANSFERASE

公开(公告)号：US20140161782A1

公开(公告)日：2014-06-12

申请号：US14182141

申请日：2014-02-17

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh

IPC分类号： C12N5/0783 , A61K35/14

CPC分类号： C12N5/0638 , A61K35/17 , A61K2035/124 , C12N5/0006 , C12N5/0623 , C12N5/0637 , C12N5/0647 , C12N5/0663 , C12N2501/724 , C12Y204/01065

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

摘要翻译： 公开了用于通过离体处理后细胞膜性质的改变来增加细胞的方法，物质组合物和试剂盒。